Microdeletion 3q13.2q21.2 in a Patient Previously Diagnosed with MOMO Syndrome

Mol Syndromol. 2024 Dec;15(6):523-530. doi: 10.1159/000538012. Epub 2024 Mar 27.

Abstract

Background: MOMO syndrome is a rare disorder with variable presentation and unknown etiology belonging to the overgrowth syndromes group.

Case presentation: The authors describe a patient presenting with severe developmental delay, absent speech, autism spectrum disorder, central nervous system malformations, bilateral optic atrophy, and postnatal overgrowth, besides a dysmorphic and progressive coarse face. A clinical diagnosis of MOMO syndrome was proposed, but he developed megaesophagus, megacolon, paraparesis, and severe acne during the clinical follow-up, which are not described in this condition. Whole-genome sequencing detected a deletion of 11.9 Mb at 3q13.2q21.2 comprising 80 genes, including the ZBTB20 gene associated with Primrose syndrome.

Conclusion: Despite the atypical manifestations in this patient, the overlapping features between MOMO syndrome, Primrose syndrome, and 3q13.31 deletion led the authors to propose that MOMO syndrome could be part of the Primrose/3q13.31 microdeletion syndrome spectrum.

Keywords: Deletion 3q13.2q21.2; MOMO syndrome; Neurodevelopmental disorders; Overgrowth syndromes; Primrose syndrome; ZBTB20.

Grants and funding

This research was made possible through access to the data and findings generated by the Rare Genomes Project, an initiative of Hospital Israelita Albert Einstein in partnership with the Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde (PROADI-SUS) from the Brazilian Ministry of Health (25000.083098/2019-71).